GlassScriptPrepare for your visit
David M Rodin
Urology · Stuart, FL · NPI 1841271038
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,331.31
in general payments reported to CMS, 2019-2025 · $163 in 2025
The $163 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $223.84
- Endo Pharmaceuticals INC. $197.29
- Coloplast Corp $182.75
- Axonics, INC. $140.80
- Sumitomo Pharma America, INC. $104.03
- Incyte Corporation $65.58
Drugs and devices associated with these payments
Qulipta Ubrelvy Orgovyx Opzelura Skyrizi Jatenzo Eligard Spevigo Lupron Depot Odomzo Blu-U Anktiva
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw David Rodin listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/174949/david-m-rodin